As we previously reported, hand-foot syndrome was the strongest factor in decreasing QoL so that multi-kinase inhibitors, EGFR-TKI, and capecitabine require careful prevention, early detection, and daily medical care [22]. The gene discussed is EGFR; the disease is Hand-foot syndrome.